We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Cutting Edge All-in-One Equipment Can Turn 600 Square Feet Room into COVID-19 Testing Lab

By LabMedica International staff writers
Posted on 26 Oct 2020
Vessel Medical (Greenville, SC, USA) has introduced Lab in a Box which comprises cutting edge all-in-one equipment that can turn a 600 square feet room into a COVID-19 testing lab.

Developed by scientists and technicians in partnership with Hamilton Company, Thermo Fisher, Grenova, and Premier Medical Laboratory Services, Lab in a Box enables a high capacity of onsite diagnostics for hospitals, expanding laboratories, schools, and large companies in need of quick and accurate testing results. More...
The turnkey equipment that includes everything needed for professional laboratory level diagnostic is expected to radically change the landscape of COVID-19 testing. Each turnkey lab solution includes the latest cutting edge technology that is pre-validated - all that is required is a brief onsite validation before testing can begin. With precision robotic instruments, Lab in a Box has high throughput liquid handling along with automated, custom-programmable pipetting that decreases human error and result turnaround time. Additionally, Vessel Medical’s Laboratory Information System (LIS) that is included reduces the result analysis time while increasing capacity exponentially. The key features of Lab in a Box help companies to begin testing and to maintain a testing flow uninterrupted.

Aside from COVID-19 assays, companies, expanding labs, and organizations can easily pivot their workflow to include detection of other common pathogens as well as genetic testing with upper respiratory, antibiotic resistance, pharmacogenomics, cancer risk screening, Flu A & B, and Std/UTI assays. Vessel Medical expects in-house testing with its Lab in a Box to allow companies to save millions of dollars annually in testing expenses. For example, a company that processes 3,000 tests per day can save just under USD 200,000 per day when compared to outsourced testing, while companies that process 12,000 tests per day can save up to USD 600,000 per day with its turnkey equipment.

“We developed Lab in a Box with the goal of providing the most efficient solution for companies and organizations to provide quality COVID-19 testing,” said Kevin Murdock, Founder of Vessel Medical. “This equipment conveniently provides the most cutting edge technology for accurate testing while saving time and money. We’re happy to help protect businesses, organizations and the people who work for them.”

Related Links:
Vessel Medical


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.